By Maksym Misichenko · Yahoo Finance ·
What AI agents think about this news
The panel agrees that the market is experiencing a rotation, not a breakdown, with defensive sectors like healthcare leading the way. However, they disagree on the sustainability of current valuations, with some expressing concern about margin compression due to slowing AI capex and productivity revisions, while others see potential support from rate relief and selective AI ROI improvements.
Risk: Margin compression due to slowing AI capex and productivity revisions
Opportunity: Potential support from rate relief and selective AI ROI improvements
This analysis is generated by the StockScreener pipeline — four leading LLMs (Claude, GPT, Gemini, Grok) receive identical prompts with built-in anti-hallucination guards. Read methodology →
The S&P 500 Index ($SPX) (SPY) today is up +0.02%, the Dow Jones Industrial Average ($DOWI) (DIA) is up +1.49%, and the Nasdaq 100 Index ($IUXX) (QQQ) is down -0.90%. June E-mini S&P futures (ESM26) are up +0.02%, and June E-mini Nasdaq futures (NQM26) are down -0.86%.
Stock indexes are mixed today, with the Dow Jones industrials posting a new all-time high. The broader market is under pressure today amid weakness in technology stocks. Broadcom is down more than -14% to lead chipmakers lower after its forecast for artificial-intelligence revenue in the current quarter fell short of expectations. Also, CrowdStrike Holdings is down more than -8% to lead cybersecurity stocks lower, despite reporting better-than-expected Q1 earnings, as the report wasn’t strong enough to lift the stock, which has more than doubled from a March low. However, the strength in managed healthcare stocks today is limiting overall market losses and helping push the Dow Jones Industrial Average to a new record high.
Weaker crude oil prices are a positive factor for stocks and bonds, with WTI crude oil down more than -3% today after the US late Wednesday said Israel and Lebanon agreed to a ceasefire if Hezbollah also stops fighting and withdraws militants from areas near the border with Israel. The agreement would require the Lebanese army to take over after the withdrawal of Israeli troops. Iran insists a deal with the US requires a ceasefire in Lebanon. Iranian Foreign Minister Abbas Araghchi said that “Communications between Iran and the US have not been cut off, but no tangible progress has been achieved in the negotiating process.”
Today’s US economic news was mixed for stocks after weekly jobless claims rose more than expected to a 3.75-month high and Q1 nonfarm productivity was revised lower. Conversely, Q1 unit labor costs were unexpectedly revised lower, easing concerns over wage pressures.
US weekly initial unemployment claims rose +13,000 to a 3.75-month high of 225,000, showing a weaker labor market than expectations of 215,000.
US Q1 nonfarm productivity was revised downward to 0.3% from the previously reported 0.8%, weaker than expectations of 0.4%. Q1 unit labor costs were unexpectedly revised downward to 1.8% from 2.3%, weaker than expectations of an upward revision to 2.4%.
The markets are discounting a 2% chance of a +25 bp rate hike at the next FOMC meeting on June 16-17.
The generally favorable Q1 earnings season is winding down. As of today, 84% of the 485 S&P 500 companies that reported Q1 earnings have beaten estimates. Q1 S&P 500 earnings are projected to climb +12% y/y, according to Bloomberg Intelligence. Stripping out the technology sector, Q1 earnings are projected to increase around +3%, the weakest in two years.
Overseas stock markets are mixed today. The Euro Stoxx 50 is up +0.51%. China's Shanghai Composite closed down -0.64%. Japan's Nikkei Stock Average closed down -1.36%.
Interest Rates
September 10-year T-notes (ZNU6) today are up +8 ticks, and the 10-year T-note yield is down -3.6 bp to 4.459%. T-note prices are moving higher today, supported by a -2% decline in WTI crude oil prices, which has lowered inflation expectations. The 10-year breakeven inflation rate fell to a 6-week low of 2.366% today. Fed-friendly US economic news was also positive for T-notes, following weekly jobless claims that rose more than expected and Q1 unit labor costs that were unexpectedly revised lower.
European government bond yields are moving lower today. The 10-year German Bund yield fell from a 1.5-week high of 3.043% and is down -1.5 bp to 3.021%. The 10-year UK gilt yield is down -2.7 bp to 4.904%.
Eurozone Apr retail sales fell -0.4% m/m, weaker than expectations of -0.3% m/m.
Swaps are discounting a 98% chance of a +25 bp ECB rate hike at its next policy meeting on June 11.
US Stock Movers
Chipmakers and AI-infrastructure stocks are slumping today, led by a -14% plunge in Broadcom (AVGO), the largest decliner in the Nasdaq 100, after giving an outlook that was seen as underwhelming, given the industry’s AI-related demand. Also, Micron Technology (MU) is down more than -8%, and ARM Holdings Plc (ARM) is down more than -5%. In addition, Advanced Micro Devices (AMD), Qualcomm (QCOM), Sandisk (SNDK), and Lam Research (LRCX) are down more than -3%. Finally, Western Digital (WDC), Seagate Technology Holdings Plc (STX), Analog Devices (ADI), KLA Corp (KLAC), and Intel (INTC) are down more than -2%.
Cryptocurrency-exposed stocks are falling today, with Bitcoin (^BTCUSD) down more than -1% at a 3.75-month low. Galaxy Digital Holdings (GLXY) is down more than -5%, MARA Holdings (MARA) is down more than -4%, and Riot Platforms (RIOT) is down more than -3%. Also, Coinbase Global (COIN) is down -0.28%.
Humana (HUM) is up more than +7% to lead managed healthcare stocks higher and gainers in the S&P 500 after Morgan Stanley raised its price target on the stock to $240 from $217. Also, Centene (CNC) is up more than +6%, and UnitedHealth Group (UNH) is up more than +5% to lead gainers in the Dow Jones Industrials after Bank of America Global Research upgraded the stock to buy from neutral with a price target of $450. In addition, Elevance Health (ELV), Cigna Group (CI), and Molina Healthcare(MOH) are up more than +4%, and CVS Health (CVS) and Cardinal Health (CAH) are up more than +2%.
PVH Corp (PVH) is down more than -24% after forecasting 2027 adjusted EPS of $11.80 to $12.10, weaker than the consensus of $12.24.
Ciena Corp (CIEN) is down more than -18% to lead losers in the S&P 500 despite reporting better-than-expected Q2 earnings, as Bloomberg Intelligence said the company’s full-year sales outlook may be viewed as underwhelming amid heightened expectations.
Five Below (FIVE) is down more than -13% despite reporting stronger-than-expected Q1 earnings results, as Jeffries said the company’s growth rate might be peaking.
CrowdStrike Holdings (CRWD) is down more than -7% after its Q1 earnings beat wasn’t strong enough to lift the stock, which has more than doubled from a March low.
Alnylam Pharmaceuticals (ALNY) is up more than +5% to lead gainers in the Nasdaq 100 after entering into a strategic AI collaboration with Inceptive Nucleics valued at up to $2 billion to accelerate the discovery and design of RNAi therapeutics.
Medtronic Plc (MDT) is up more than +4% after BTIG LLC upgraded the stock to buy from neutral with a price target of $90.
Zoetis (ZTS) is up more than +4% after KeyBanc Capital Markets said the cattle screwworm parasite could be a potential catalyst for the company’s livestock portfolios, as it has approved medications to prevent and treat the parasite in livestock.
RTX Corp (RTX) is up more than +3% after Jeffries upgraded the stock to buy from hold with a price target of $220.
Brown-Forman (BF.B) is up more than +1% after reporting Q4 gross margin of 62.6%, stronger than the consensus of 57.5%.
Earnings Reports(6/4/2026)
Brown-Forman Corp (BF/B), Ciena Corp (CIEN), Cooper Cos Inc/The (COO), Docusign Inc (DOCU), Guidewire Software Inc (GWRE), Lululemon Athletica Inc (LULU), Rubrik Inc (RBRK), Samsara Inc (IOT), Toro Co/The (TTC).
Four leading AI models discuss this article
"The market is undergoing a healthy valuation reset rather than a structural decline, with capital rotating from overextended AI growth into defensive, high-margin sectors."
The market is exhibiting a classic rotation, not a breakdown. While tech/AI names like Broadcom (AVGO) are correcting due to stretched valuations and 'priced-for-perfection' guidance, the Dow’s record high on the back of managed healthcare (UNH, HUM) signals a defensive shift toward quality and cash flow. The downward revision in unit labor costs is the most critical data point; it suggests the Fed may have more room to maneuver than previously thought, despite the headline productivity miss. Investors are clearly rotating out of high-multiple growth into value sectors that offer predictable margins, setting a healthier floor for the broader index as the earnings season concludes.
The rotation into defensive healthcare may be a 'value trap' masking a broader deceleration in consumer spending, as evidenced by the sharp sell-off in retail names like PVH and Five Below.
"Broadcom's AI revenue shortfall plus softer productivity data signal that tech multiples face re-rating risk as growth expectations cool."
The article frames today's mixed session as tech weakness offset by healthcare and Dow strength, but the Broadcom AI forecast miss plus downward productivity revision to 0.3% and claims rising to 225k point to fading AI momentum amid a softening labor market. This could pressure Nasdaq more than the headline suggests, especially with Q1 earnings growth outside tech at just +3%. The 2% odds of a June hike reflect dovish data, yet that may not support multiples if growth slows further.
Broadcom's miss could be company-specific while 84% of S&P 500 beat rates and the Dow's new high show underlying resilience that outweighs one sector's wobble.
"The market is rotating out of AI-infrastructure plays into defensive healthcare, but the underlying risk is that non-tech earnings growth of +3% YoY cannot sustain valuations if tech growth decelerates faster than consensus expects."
The headline 'Tech Weakness Weighs' obscures a more nuanced picture: mega-cap healthcare is doing the heavy lifting (HUM +7%, UNH +5%, managed care outperformance), and the Dow hitting ATH while Nasdaq falls suggests a rotation, not a crash. The real concern is buried: Q1 ex-tech earnings growth is only +3% YoY—the weakest in two years. Broadcom's AI revenue miss (-14%) and Ciena's guidance disappointment (-18%) despite beats signal that the market is repricing AI capex expectations downward. Jobless claims at a 3.75-month high plus productivity revision to 0.3% (from 0.8%) hints at labor market softening that could pressure margins if not offset by AI-driven efficiency gains. The 2% odds on a June rate hike is dovish tailwind, but that's priced in.
If the AI capex cycle is genuinely slowing (Broadcom's miss suggests it), then the 12% YoY S&P 500 earnings growth is frontloaded by tech and will decelerate sharply in H2 2026, making today's rotation look like the beginning of a broader earnings disappointment, not a healthy rebalancing.
"The risk to equities is tilted toward a tech-led pullback as breadth narrows and AI-driven growth slows, making near-term downside more likely than the article suggests."
Takeaway: the session looks mixed, but the undercurrents warn of a risk-off tilt despite a Dow hit new highs. The breadth is skewed toward resistance in tech (QQQ down ~0.9%, AVGO -14%, MU -8%), while defensive and healthcare names are the few pockets of buoyancy. Earnings momentum ex-technology is weak, with +3% y/y projected outside tech, and Q2 price action could hinge on whether AI demand surprises to the upside. Macro data provides mixed signals: productivity revisions ease wage fears, yet the labor market softening could shift Fed policy. If the tech bid stays weak, valuation support vanishes quickly.
The strongest counterpoint is that breadth is deteriorating with tech leading the weakness; a continued AI capex slowdown could trigger a broader earnings re-rating. If Q2 guidance disappoints or geopolitics reintroduce risk premia, the Dow's leadership may falter and Nasdaq could extend declines.
"The combination of weak ex-tech earnings and lower productivity renders current index valuations unsustainable if AI efficiency gains fail to materialize."
Claude, your focus on the +3% ex-tech earnings growth is the real story, but you’re missing the secondary implication: if the AI capex cycle is indeed peaking, we aren't just looking at a rotation, but a margin compression event. If companies can't realize efficiency gains from AI investments to offset rising labor costs—now that productivity is revised down to 0.3%—the S&P 500's current 21x forward P/E becomes fundamentally unsustainable, regardless of defensive healthcare gains.
"Softer productivity and labor data tilt policy dovish enough to buffer valuations despite AI weakness."
Gemini, the 0.3% productivity revision paired with 225k claims does not automatically trigger margin compression. It instead raises the odds of earlier Fed cuts beyond the current 2% June hike probability, which would support multiples even with AI capex slowing. The overlooked link is that this macro relief could extend the Dow's defensive bid into H2 rather than expose the +3% ex-tech earnings floor as unsustainable.
"Fed cuts on weak productivity data signal growth deceleration, not multiple support—the rotation is a warning, not a floor."
Grok's Fed-cut tailwind assumes productivity miss stays isolated to labor costs. But 0.3% productivity revision signals broader capex ROI deterioration—not just wages. If AI investments aren't generating expected output gains, earlier cuts don't rescue multiples; they just reflect slower growth. The Dow's healthcare bid masks that ex-tech earnings at +3% YoY can't sustain 21x forward P/E even with rate relief. Defensive rotation is rational, not supportive.
"AI ROI deterioration alone isn't enough to justify margin compression or a failed 21x P/E; buffers like buybacks and selective AI gains can sustain margins and valuations."
Gemini's margin-compression concern hinges on AI ROI deteriorating uniformly; but 0.3% productivity and ongoing buybacks provide buffers that can keep margins from collapsing. A healthcare-led rotation supports earnings defense, yet a broad P/E re-rating is not off the table if rates stay supportive and AI ROI strengthens selectively. In short, 21x forward P/E isn’t automatically unsustainable; it depends on ROIC diffusion, not a single AI-cycle critique.
The panel agrees that the market is experiencing a rotation, not a breakdown, with defensive sectors like healthcare leading the way. However, they disagree on the sustainability of current valuations, with some expressing concern about margin compression due to slowing AI capex and productivity revisions, while others see potential support from rate relief and selective AI ROI improvements.
Potential support from rate relief and selective AI ROI improvements
Margin compression due to slowing AI capex and productivity revisions